We are the trusted Exporter and Supplier of
Deflamas-6 Tablets. Following clinical trials over more than 20 years, Deflamas-6 Tablets have been approved in many countries (Italy, France, UK, Germany, and Spain) for use in inflammatory diseases. With regard to its effect, it has been claimed to have, at doses with equivalent anti-inflammatory efficacy to prednisolone, less severe adverse effects on bone.
Indication - Inflammatory Disorders
- Autoimmune Diseases
- Prevention and treatment for rejection of organ transplant
- Certain Types of Cancers
Composition : Deflazacort - 6 mg.